Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0000950144-09-003082
Filing Date
2009-04-10
Accepted
2009-04-09 17:49:53
Documents
4

Document Format Files

Seq Description Document Type Size
1 CUMBERLAND PHARMACEUTICALS, INC. c0628617sv1za.htm S-1/A 1854553
2 EX-23.1 c0628617exv23w1.htm EX-23.1 2689
3 GRAPHIC c0628617c0628602.gif GRAPHIC 3768
4 GRAPHIC c0628617c0628610.gif GRAPHIC 337
  Complete submission text file 0000950144-09-003082.txt   1864559
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: S-1/A | Act: 33 | File No.: 333-142535 | Film No.: 09743698
SIC: 2834 Pharmaceutical Preparations